Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2005
03/16/2005CN1593457A Anti infection agent and its application
03/16/2005CN1593456A Desensitization face pack for treating facial dermatitis
03/16/2005CN1593428A Dextran-aspirin combined medicine and its preparation method
03/16/2005CN1593425A Compound hyacinth bletilla minipill
03/16/2005CN1593416A Method for preserving and preparing hydroxycamptothecine ring closure injection
03/16/2005CN1593403A Colon positioning and adhering preparation and its preparing process
03/16/2005CN1193059C Neutral lipopolymer and liposomal compositions containing same
03/16/2005CN1193048C 聚合物水分散体 Aqueous polymer dispersions
03/16/2005CN1192803C Injectable in situ solidification cement with inorganic framework and application in micro traumatic treatment
03/16/2005CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV)
03/16/2005CN1192796C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
03/16/2005CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability
03/16/2005CN1192766C Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates
03/16/2005CN1192765C New and improved formulation for paclitaxel
03/15/2005US6867275 Solid media
03/15/2005US6867248 Polyhydroxyalkanoate compositions having controlled degradation rates
03/15/2005US6867238 Compositions for the treatment and prevention of cancer
03/15/2005US6867231 Therapeutic systems
03/15/2005US6867191 Preparation and use of oligopeptide lyophilisate for gonad protection
03/15/2005US6867190 Methods of therapy with thrombin derived peptides
03/15/2005US6867183 And fatty acid component and bile salt component; treating insulin deficiency; oral administration
03/15/2005US6867182 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
03/15/2005US6867181 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
03/15/2005US6867176 Method for preparing zinc-oligopeptide easily absorbable by the human body
03/15/2005US6867007 Binary or polynary targeting and uses thereof
03/15/2005US6866876 Obtained by hydrolyzing pyrodextrin with amylase and debranching enzyme; (sugar-free) chewing gum
03/15/2005US6866838 Composite nanospheres and their conjugates with biomolecules
03/15/2005US6866668 Methods, instruments and materials for chondrocyte cell transplantation
03/15/2005CA2317769C Sustained release microparticle and method for preparing the same
03/15/2005CA2289202C Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent
03/15/2005CA2242972C Anthelmintic paste
03/15/2005CA2217515C Pharmaceutical composition containing proton pump inhibitors
03/15/2005CA2150119C Tastemasked pharmaceutical materials
03/15/2005CA2054325C Antisense oligonucleotides for treatment of cancer
03/10/2005WO2005021706A2 Delivery of compounds with rehydrated blood cells
03/10/2005WO2005021564A1 Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof
03/10/2005WO2005021556A2 Modified protease inhibitors
03/10/2005WO2005021044A2 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
03/10/2005WO2005021043A2 High-molecular-mass prodrugs
03/10/2005WO2005021022A2 Stable formulations of peptides
03/10/2005WO2005020965A2 Skeletally targeted nanoparticles
03/10/2005WO2005020956A2 Microparticles
03/10/2005WO2005020953A1 Spray-dried amorphous powder with a low residual moisture and excellent storage stability
03/10/2005WO2005020918A2 Ultrasonic concentration of drug delivery capsules
03/10/2005WO2005020901A2 Delivery of a therapeutic agent in a formulation for reduced toxicity
03/10/2005WO2005020900A2 Delivery of a therapeutic agent in a formulation for reduced toxicity
03/10/2005WO2005020876A2 Pharmaceutical composition, method of manufacturing and therapeutic use thereof
03/10/2005WO2005003722A3 Nanotube structures having a surfactant bilayer inner wall coating
03/10/2005WO2004105492A8 Aqueous compositions for disinfection and/or sterilization
03/10/2005WO2004100826A3 Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
03/10/2005WO2004082627A3 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2
03/10/2005WO2004081031A3 Thiol-mediated drug attachment to targeting peptides
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003072542A3 Interfacial biomaterials
03/10/2005WO2003072046A3 Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054816 Endcapping a water-soluble and non-peptidic polymer having two hydroxyl groups, e.g., polyoxyethylene glycol, to form a blend of mono-ols, diols, and diendcapped polymer; ion exchange purifying to obtain only the mono-ol; protective coatings for proteins; medical equipment; biopolymer carrier; hydrogels
03/10/2005US20050054768 Multifunctional biocompatible hydrophilic gel and the method of gel manufacture
03/10/2005US20050054726 Vaccine
03/10/2005US20050054719 Dimeric compounds and their use as anti-viral agents
03/10/2005US20050054718 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency
03/10/2005US20050054716 such as 7-O-methylthiomethylpaclitaxel having improved solubility, stability and oxidation resistance, for use as antitumor or anticarcinogenic agents
03/10/2005US20050054682 Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054611 Composition and method for use in intestinal cleansing procedures
03/10/2005US20050054607 Reaction product of drug, spacer and vitamin b12; drug delivery
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054598 RNA interference mediated inhibition hairless (HR) gene expression using short interfering nucleic acid (siNA)
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
03/10/2005US20050054583 Composition for an antifungal agent for suppressing fungal growth in an oral cavity
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054561 Abuse-resistant amphetamine compounds
03/10/2005US20050054559 Compounds for sustained release of orally delivered drugs
03/10/2005US20050054555 Kahalalide compounds for use in cancer therapy
03/10/2005US20050054551 Alkyl-and/or alkylene oligoglycoside betaine ester quaternaries
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054051 Albumin fusion proteins
03/10/2005US20050054016 Determination of bone-sialoprotein in bodily fluids for oncological problems
03/10/2005US20050053990 Identifying RNA viral sequences using restriction enzymes specific for RNA/DNA duplexes; primer biosynthesis; pathogen detection
03/10/2005US20050053681 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/10/2005US20050053675 Method of making, and the use of cytotoxic agents containing elemental selenium
03/10/2005US20050053670 use of an organic lubricant and no alkali metal salts of metaphosphates in an effective amount into the birth canal of the woman during delivery
03/10/2005US20050053668 allows targeted delivery of bioactive factors to bone using nanocapsules having an amphipathic surface made of polyethylene glycol-modified phospholipid
03/10/2005US20050053667 a hydrogel polymer; an immunogen encapsulated in said hydrogel particle; a ligand on a surface of hydrogel particle, interacts with an antigen presenting cell and providing an activation signal to antigen presenting cell
03/10/2005US20050053664 Reduced toxicity; enhance efficiency; side effect reduction; anticarcinogenic agent; administering to a cancer patient admixture having (((1,4)-linked beta -D-mannopyranose)17-((1,6)-linked- beta -D-galactopyranose)10)12) and a chemotherapeutic agent
03/10/2005US20050053661 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
03/10/2005US20050053660 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
03/10/2005US20050053654 able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt and a binder, in the form of a coated granule, and excipients such as disintegrating agent, a soluble diluent, and a lubricant
03/10/2005US20050053647 Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
03/10/2005US20050053646 Pressure-sensitive adhesive and patch employing the same
03/10/2005US20050053635 Topical skin care composition containing refined peanut oil
03/10/2005US20050053608 Using monoclonal antibody/maytansine fusion as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy
03/10/2005US20050053577 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs; for treatment of cancer
03/10/2005US20050051483 forskolin, isoforskolin or 7-deacetylforskolin complexing/solubilizing with cyclodextrin agent; ophthamology
03/10/2005CA2546482A1 Compositions and methods for delivery of biologically active agents
03/10/2005CA2537610A1 Pharmaceutical composition, method of manufacturing and therapeutic use thereof
03/10/2005CA2537113A1 Modified protease inhibitors
03/10/2005CA2536442A1 Potentiation of the activation of high-molecular-mass prodrugs
1 ... 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 ... 1712